New Global Collaboration On Inspecting Sterile Drug Manufacturers
Initiative Builds On Success Of Similar Program For API Inspections
Executive Summary
Drug regulatory authorities from around the world are participating in a new initiative that allows them to collaborate on the inspection of manufacturers of sterile medicines located in third countries.
You may also be interested in...
Report: Global API GMP Inspection Coordination Increasing Under Joint Program
Regulators report that an international collaboration on GMP inspections of API sites has bolstered the exchange of information between participating health authorities, yet the information technology system that supports the system could use some improvement.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.